Status:
COMPLETED
Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy
Lead Sponsor:
University Health Network, Toronto
Conditions:
Elevated PSA
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Prostate specific antigen (PSA) and digital rectal exam (DRE) are used to screen for prostate cancer. Patients with abnormal DRE or elevated PSA undergo transrectal ultrasound guided biopsy (TRUS-Bx)....
Detailed Description
Prostate specific antigen (PSA) and digital rectal exam (DRE) are used to screen for prostate cancer. Patients with abnormal DRE or elevated PSA undergo transrectal ultrasound guided biopsy (TRUS-Bx)....
Eligibility Criteria
Inclusion
- prior ultrasound biopsy of prostate showing no cancer or only single microfocus of cancer
Exclusion
- contraindication to contrast enhanced endorectal coil MRI
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
End Date :
November 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00242060
Start Date
November 1 2002
End Date
November 1 2008
Last Update
July 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9